Virtu Financial LLC Enochian Biosciences Inc Transaction History

Virtu Financial LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 26, 2024	BUY	$4.3 - $4.7 $79,438 - $86,827	18,474 New	18,474 $59,000
Q2 2023 Jul 27, 2023	BUY	$0.4 - $1.3 $4,411 - $14,337	11,029 New	11,029 $6,000
Q1 2022 May 17, 2022	SELL	$4.42 - $9.0 $98,725 - $201,024	-22,336 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$6.71 - $12.55 $149,874 - $280,316	22,336 New	22,336 $163,000
Q3 2021 Nov 12, 2021	SELL	$4.56 - $7.88 $310,111 - $535,895	-68,007 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$2.94 - $6.79 $199,940 - $461,767	68,007 New	68,007 $338,000
Q1 2021 May 19, 2021	SELL	$3.02 - $4.51 $53,873 - $80,453	-17,839 Closed	0 $0
Q4 2020 Feb 24, 2021	BUY	$2.82 - $3.55 $50,305 - $63,328	17,839 New	17,839 $53,000

14.7M

24K

19.1K

Ticker ENOB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,950,000
Market Cap $244M
Description
Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.